(Q46563583)

23 December 2017

title

Does metformin decrease blood pressure in patients with Type 2 diabetes intensively treated with insulin? (English)

1 reference

23 December 2017

1 reference

1 reference

1 reference

Wulffelé MG

1

1 reference

23 December 2017

Kooy A

2

1 reference

23 December 2017

Lehert P

3

1 reference

23 December 2017

Bets D

4

1 reference

23 December 2017

Donker AJ

5

1 reference

23 December 2017

Stehouwer CD

6

1 reference

23 December 2017

publication date

1 July 2005

1 reference

23 December 2017

published in

Diabetic Medicine

1 reference

23 December 2017

volume

22

1 reference

23 December 2017

issue

7

1 reference

23 December 2017

page(s)

907-913

1 reference

23 December 2017

Acute hyperinsulinemia induces sodium retention and a blood pressure decline in diabetes mellitus

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01554.X

Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01554.X

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01554.X

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01554.X

The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01554.X

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01554.X

Effects of short‐term treatment with metformin on serum concentrations of homocysteine, folate and vitamin B12 in type 2 diabetes mellitus: a randomized, placebo‐controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01554.X

Metabolic and haemodynamic effects of metformin in patients with type 2 diabetes mellitus and hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01554.X

Homocysteine and blood pressure in the Third National Health and Nutrition Examination Survey, 1988-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01554.X

Ambulatory blood pressure monitoring in the evaluation of drug efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01554.X

Variability of indirect methods used to determine blood pressure. Office vs mean 24-hour automated blood pressures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01554.X

Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01554.X

Simultaneous glyburide/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01554.X

The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01554.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01554.X

The effects of metformin on cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01554.X

10.1111/J.1464-5491.2005.01554.X

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017